Clinical Trial Update: A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of a personalized PSMA radiopharmaceutical therapy for prostate cancer is not yet recruiting. The trial includes metastatic prostate cancer and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Personalized PSMA radiopharmaceutical therapy

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Cancer, Prostate Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING